CALQUENCE

Capsule, hard, 100mg
RxActive license

Active substance (INN)

acalabrutinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength100mg
PackagingUkupno 56 kapsula tvrdih u blisteru (7x8) u kartonskoj kutiji
ManufacturerAstraZeneca AB, Sweden
Therapeutic groupAntineoplastic and immunomodulating agents (L01EL02)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateDecember 12, 2022

Analogs in Montenegro

3

Other medicines with the same active substance

CALQUENCERx
Capsule, hard, 100mgAstraZeneca AB
CALQUENCERx
Film-coated tablet, 100mgAstraZeneca AB
CALQUENCERx
Film-coated tablet, 100mgAstraZeneca AB
Source: CInMED register